JPH07506356A - 眼用の医薬製剤およびその製造方法 - Google Patents
眼用の医薬製剤およびその製造方法Info
- Publication number
- JPH07506356A JPH07506356A JP5519012A JP51901293A JPH07506356A JP H07506356 A JPH07506356 A JP H07506356A JP 5519012 A JP5519012 A JP 5519012A JP 51901293 A JP51901293 A JP 51901293A JP H07506356 A JPH07506356 A JP H07506356A
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical formulation
- tablets
- formulation according
- tablet
- active ingredient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts, ocular implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (13)
- 1.内部から外部に向けて、 −少なくとも1種のポリマーからなり、かつ少なくとも1種の有効成分を含有す る基材、 −グリセリドの第1の層、 を有することを特徴とする眼に投与するための医薬製剤。
- 2.さらに、半透性の外膜を形成する第2の層を有する請求項1記載の医薬製剤 。
- 3.錠剤である請求項1または2記載の医薬製剤。
- 4.基材に使用するポリマーが、ポリエチレン、アクリル系ポリマー、ポリ塩化 ビニル、HPMC型セルロース誘導体、ポリビニルアルコール、オイドラギット (登録商標)またはそれらの混合物からなる群から選択される、請求項1〜3の いずれかに記載の医薬製剤。
- 5.グリセリドが天然または半合成固体グリセリドである請求項1〜4のいずれ かに記載の医薬製剤。
- 6.グリセリドがコンプリトール(登録商標)である請求項5記載の医薬製剤。
- 7.半透膜がセルロース、例えばエチルセルロースの熱可塑性誘導体から形成さ れる請求項2〜6のいずれかに記載の医薬製剤。
- 8.有効成分が散瞳薬、抗生物質および抗炎症薬からなる群から選択される請求 項1〜7のいずれかに記載の医薬製剤。
- 9.錠剤の全重量に対して有効成分が1〜60%、基材のポリマーが25〜75 %、グリセリドが8〜40%存在する、請求項1〜8のいずれかに記載の医薬製 剤。
- 10.長さが約2.5〜4mmであり、直径が約1〜3mmである請求項1〜9 のいずれかに記載の医薬製剤。
- 11.以下の工程を行うことを特徴とする、請求項1〜10のいずれかに記載の 医薬製剤を製造する方法。 a)1種またはそれ以上の有効成分を、基材を構成する1種またはそれ以上のポ リマーと混合する、 b)必要に応じ、湿潤化および補助剤の添加後に得られる混合物を顆粒化する、 c)グリセリドを添加し混合する、 d)前工程の最後に得られる混合物を直接錠剤化する。
- 12.工程d)の後に、有機溶媒に溶解した熱可塑性誘導体で錠剤を被覆する工 程を行うことを特徴とする、請求項2〜10のいずれかに記載の錠剤を製造する 請求項11記載の方法。
- 13.錠剤をエチルセルロースの有機溶剤の溶液に浸漬し、次いで乾燥器中で乾 燥することにより、被覆を行うことを特徴とする請求項12記載の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR92/05514 | 1992-05-05 | ||
FR9205514A FR2690846B1 (fr) | 1992-05-05 | 1992-05-05 | Forme galenique pour administration oculaire et procede de preparation. |
PCT/FR1993/000433 WO1993021901A1 (fr) | 1992-05-05 | 1993-05-05 | Forme galenique pour administration oculaire et procede de preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH07506356A true JPH07506356A (ja) | 1995-07-13 |
JP3208568B2 JP3208568B2 (ja) | 2001-09-17 |
Family
ID=9429535
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP51901293A Expired - Fee Related JP3208568B2 (ja) | 1992-05-05 | 1993-05-05 | 眼用の医薬製剤およびその製造方法 |
Country Status (8)
Country | Link |
---|---|
US (1) | US5766619A (ja) |
EP (1) | EP0639069B1 (ja) |
JP (1) | JP3208568B2 (ja) |
KR (1) | KR100206481B1 (ja) |
DE (1) | DE69314950T2 (ja) |
ES (1) | ES2109493T3 (ja) |
FR (1) | FR2690846B1 (ja) |
WO (1) | WO1993021901A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007013590A1 (ja) * | 2005-07-29 | 2007-02-01 | Santen Pharmaceutical Co., Ltd. | 固形組成物を用いた後眼部組織への非侵襲性ドラッグデリバリーシステム |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19511322C2 (de) | 1995-03-28 | 1999-09-02 | Mann Gerhard Chem Pharm Fab | Sterile Augengele mit einem Gehalt an mittelkettigen Triglyceriden und Verfahren zu deren Herstellung |
EP1154691A4 (en) * | 1999-01-05 | 2004-07-07 | Massachusetts Eye & Ear Infirm | TARGETED ADMINISTRATION OF REGULATED RELEASE MEDICINE TO RETINA AND CHOROID THROUGH SCLEROTIC |
US6416777B1 (en) | 1999-10-21 | 2002-07-09 | Alcon Universal Ltd. | Ophthalmic drug delivery device |
US7943162B2 (en) * | 1999-10-21 | 2011-05-17 | Alcon, Inc. | Drug delivery device |
CA2383572C (en) | 1999-10-21 | 2007-12-11 | Alcon Universal Ltd. | Sub-tenon drug delivery |
WO2001028472A1 (en) | 1999-10-21 | 2001-04-26 | Alcon Universal Ltd. | Drug delivery device |
WO2002089767A1 (en) | 2001-05-03 | 2002-11-14 | Massachusetts Eye And Ear Infirmary | Implantable drug delivery device and use thereof |
BR0210287A (pt) * | 2001-07-23 | 2005-12-13 | Alcon Inc | Dispositivo de administração de droga oftalmológica |
DK1409065T3 (da) | 2001-07-23 | 2007-05-21 | Alcon Inc | Oftalmisk medikamentafgivelsesanordning |
WO2003092665A2 (en) * | 2002-05-02 | 2003-11-13 | Massachusetts Eye And Ear Infirmary | Ocular drug delivery systems and use thereof |
US20060167435A1 (en) * | 2003-02-18 | 2006-07-27 | Adamis Anthony P | Transscleral drug delivery device and related methods |
CN1882338A (zh) * | 2003-09-18 | 2006-12-20 | 马库赛特公司 | 经巩膜递送 |
US8663639B2 (en) * | 2005-02-09 | 2014-03-04 | Santen Pharmaceutical Co., Ltd. | Formulations for treating ocular diseases and conditions |
ES2564194T3 (es) | 2005-02-09 | 2016-03-18 | Santen Pharmaceutical Co., Ltd. | Formulaciones líquidas para el tratamiento de enfermedades o dolencias |
CA2616537A1 (en) | 2005-07-27 | 2007-02-01 | University Of Florida Research Foundation, Inc. | Small compounds that correct protein misfolding and uses thereof |
CA2631173A1 (en) | 2005-11-29 | 2007-06-07 | Smithkline Beecham Corporation | Treatment method |
BRPI0707612B8 (pt) | 2006-02-09 | 2021-05-25 | Macusight Inc | vaso lacrado e formulações líquidas contidas no mesmo |
US8222271B2 (en) | 2006-03-23 | 2012-07-17 | Santen Pharmaceutical Co., Ltd. | Formulations and methods for vascular permeability-related diseases or conditions |
US20080265343A1 (en) * | 2007-04-26 | 2008-10-30 | International Business Machines Corporation | Field effect transistor with inverted t shaped gate electrode and methods for fabrication thereof |
US8632511B2 (en) | 2009-05-06 | 2014-01-21 | Alcon Research, Ltd. | Multiple thermal sensors in a multiple processor environment for temperature control in a drug delivery device |
IN2012DN00352A (ja) | 2009-06-16 | 2015-08-21 | Bikam Pharmaceuticals Inc | |
US20120232102A1 (en) | 2009-09-30 | 2012-09-13 | Chun-Fang Xu | Methods Of Administration And Treatment |
US8177747B2 (en) | 2009-12-22 | 2012-05-15 | Alcon Research, Ltd. | Method and apparatus for drug delivery |
WO2012174064A1 (en) | 2011-06-14 | 2012-12-20 | Bikam Pharmaceuticals, Inc. | Opsin-binding ligands, compositions and methods of use |
EP2768307B1 (en) | 2011-10-19 | 2020-03-18 | Bikam Pharmaceuticals, Inc. | Opsin-binding ligands, compositions and methods of use |
EP2944628B1 (en) | 2011-11-30 | 2017-01-04 | Bikam Pharmaceuticals, Inc. | Opsin-binding ligands, compositions and methods of use |
WO2013081642A1 (en) | 2011-12-01 | 2013-06-06 | Bikam Pharmaceuticals, Inc. | Opsin-binding ligands, compositions and methods of use |
CN109549922B (zh) * | 2018-12-27 | 2021-04-20 | 湖北远大天天明制药有限公司 | 一种托吡卡胺眼用组合物及其制备方法与应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3630200A (en) * | 1969-06-09 | 1971-12-28 | Alza Corp | Ocular insert |
SE352811B (ja) * | 1971-06-04 | 1973-01-15 | Pharmacia Ab | |
US3986510A (en) * | 1971-09-09 | 1976-10-19 | Alza Corporation | Bioerodible ocular device |
US3828777A (en) * | 1971-11-08 | 1974-08-13 | Alza Corp | Microporous ocular device |
-
1992
- 1992-05-05 FR FR9205514A patent/FR2690846B1/fr not_active Expired - Lifetime
-
1993
- 1993-05-04 US US08/331,603 patent/US5766619A/en not_active Expired - Lifetime
- 1993-05-05 EP EP93910086A patent/EP0639069B1/fr not_active Expired - Lifetime
- 1993-05-05 JP JP51901293A patent/JP3208568B2/ja not_active Expired - Fee Related
- 1993-05-05 ES ES93910086T patent/ES2109493T3/es not_active Expired - Lifetime
- 1993-05-05 DE DE69314950T patent/DE69314950T2/de not_active Expired - Lifetime
- 1993-05-05 WO PCT/FR1993/000433 patent/WO1993021901A1/fr active IP Right Grant
-
1994
- 1994-11-04 KR KR1019940703939A patent/KR100206481B1/ko not_active IP Right Cessation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007013590A1 (ja) * | 2005-07-29 | 2007-02-01 | Santen Pharmaceutical Co., Ltd. | 固形組成物を用いた後眼部組織への非侵襲性ドラッグデリバリーシステム |
Also Published As
Publication number | Publication date |
---|---|
DE69314950D1 (de) | 1997-12-04 |
JP3208568B2 (ja) | 2001-09-17 |
DE69314950T2 (de) | 1998-04-16 |
ES2109493T3 (es) | 1998-01-16 |
FR2690846B1 (fr) | 1995-07-07 |
US5766619A (en) | 1998-06-16 |
FR2690846A1 (fr) | 1993-11-12 |
KR100206481B1 (en) | 1999-07-01 |
EP0639069A1 (fr) | 1995-02-22 |
WO1993021901A1 (fr) | 1993-11-11 |
KR950701214A (ko) | 1995-03-23 |
EP0639069B1 (fr) | 1997-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH07506356A (ja) | 眼用の医薬製剤およびその製造方法 | |
DE60133538T2 (de) | Formulierung und tabletten mit guaifenesin mit verzögerter freisetzung | |
DE69629797T2 (de) | Matrix zur gesteuerten freisetzung von arzneistoffen | |
CN104958282B (zh) | 他喷他多组合物 | |
DE69632753T2 (de) | Darifenacin enthaltende pharmazeutische Zubereitungen | |
DE69535445T2 (de) | Schmelzextrudierte oral verabreichbare Opioidformulierungen | |
US5472704A (en) | Pharmaceutical controlled-release composition with bioadhesive properties | |
DE69919713T2 (de) | Pharmazeutische zubereitung mit verzögerter wirkstofffreisetzung von phenytoin natrium | |
US5133974A (en) | Extended release pharmaceutical formulations | |
DE69826290T2 (de) | Pharmazeutische zusammensetzungen zur kontrollierten freigabe von wirkstoffen | |
DE69927708T2 (de) | Dosierungsformen, die poröse partikel enthalten | |
DE20221486U1 (de) | Tamsulosin-Tabletten mit modifizierter Freisetzung | |
KR0169319B1 (ko) | 서방성 정제 | |
AT9895U1 (de) | Verfahren zur behandlung von viszeralem schmerz | |
DE69720778T2 (de) | ARZNEIMITTEL ZUR VERZÖGERTEN FREISETZUNG DES HMG-CoA REDUKTASE INHIBITORS FLUVASTATIN | |
DE1617374A1 (de) | Verfahren zum Herstellen eines pharmazeutischen Praeparates mit verzoegerter Wirkung | |
HU230828B1 (en) | Controlled release hydrocodone formulations | |
US20060263427A1 (en) | Quinine formulations | |
RO115112B1 (ro) | Compozitie orala cu eliberare controlata si metoda de tratare a unui pacient | |
AT6542U1 (de) | Tamsulosinpellets und verfahren zum herstellen derselben | |
DE602004009552T2 (de) | Orales abgabesystem mit einem antibakteriellen und einem entzündungshemmenden mittel | |
DE69929703T2 (de) | Neue orale formulierungen für 5-ht4 agonisten oder antagonisten | |
JPH09510430A (ja) | 制御された放出のカリウム投与形状 | |
DE112011101605T5 (de) | Pharmazeutische Zusammensetzung umfassend Hydromorphon und Naloxon | |
JP3064417B2 (ja) | 放出制御性製剤及び方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20070713 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080713 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090713 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100713 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110713 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120713 Year of fee payment: 11 |
|
LAPS | Cancellation because of no payment of annual fees |